NINOX, of VLX Ventures’ portfolio, raised $10 million from international and Israeli funds

Posted on Apr 22, 2015


$5 million is being raised now and a further $5 million according to milestones.

Startup company NINOX Medical has announced a $10 million financing round, with the participation of leading Israeli and overseas funds.The round will take place in two stages: $5 million will be raised immediately, and an additional $5 million according to milestones. The shareholders in the company before the round are Xenia and entrepreneur Alex Rapoport. The financing round is the company’s first, before the completion of its incubation period. Xenia will invest $250,000 both stages of the round – a total of $500,000.Ninox is developing a device for the treatment of obstructive sleep apnea (OSA) that is designed to be effective, comfortable to use, and without the side effects typical of other treatment devices. Patients with OSA suffer from repeated episodes of upper airway obstruction during sleep that disrupts the quality of their sleep and causes accompanying ailments, such as hypertension, diabetes, heart attacks, and stroke.

18 million people in the US alone suffer from OSA. The existing solutions include invasive surgical procedures and sleeping with cumbersome systems that affect the quality of the patient’s sleep. The market for treating OSA amounts to $4 billion a year, with double-digit percentage growth projected annually in the coming years.

 

logo3

News & Events

Microsoft buying Secure Islands

What stock market tumble means for the Israeli High-tech industry

How new technologies can help improve workforce productivity

Biomed startups should seek more innovative business models

VLX Ventures Summer 2015 Event- Rebuilding Traditional Business Models in Healthcare

NINOX, of VLX Ventures’ portfolio, raised $10 million from international and Israeli funds

EyeYon Medical, a graduate of VLX Ventures’ technology incubator, raised $3.6 million from leading Israeli funds

Meet VLX Ventures’ Team at the ICI Meeting 2014

Telefónica and VLX Ventures team up to invest in Israeli start-ups

VLX Ventures at Globes, October 2014

EyeYon Medical Stands Out at the Recent ESCRS Annual Meeting

An Article Published in The Marker, by Ori Choshen, VLX Ventures’ CEO

Mobile Monetization Expert Tips – Lessons Learned From VLX Ventures’ Event

VLX Ventures’ Mobile-Health 2014 Event

Meet VLX Ventures’ Team at the Israel Innovation Conference (MIXiii)

VLX Ventures’ event – MobileMonday Jerusalem: Mobile Monetization Expert Tips

Dutch Fund BOM Capital Signs Agreement with VLX Ventures

  • Microsoft buying Secure Islands
  • What stock market tumble means for the Israeli High-tech industry
  • How new technologies can help improve workforce productivity
  • “Biomed startups should seek more innovative business models”
  • VLX Ventures Summer 2015 Event- Rebuilding Traditional Business Models in Healthcare
  • NINOX, of VLX Ventures’ portfolio, raised $10 million from international and Israeli funds
  • EyeYon Medical, a graduate of VLX Ventures’ technology incubator, raised $3.6 million from leading Israeli funds
  • Meet VLX Ventures’ Team at the ICI Meeting 2014
  • Telefónica and VLX Ventures team up to invest in Israeli start-ups
  • VLX Ventures at Globes, October 2014
  • EyeYon Medical Stands Out at the Recent ESCRS Annual Meeting
  • An Article Published in The Marker, by Ori Choshen, VLX Ventures’ CEO
  • Mobile Monetization Expert Tips – Lessons Learned From VLX Ventures’ Event
  • VLX Ventures’ Mobile-Health 2014 Event
  • Meet VLX Ventures’ Team at the Israel Innovation Conference (MIXiii)
  • VLX Ventures’ event – MobileMonday Jerusalem: Mobile Monetization Expert Tips
  • Dutch Fund BOM Capital Signs Agreement with VLX Ventures